11.68p-0.07 (-0.64%)19 May 2022, 13:27
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Abingdon Health PLC Fundamentals

Company NameAbingdon Health PLCLast Updated2022-05-19
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue121.699 mMarket Cap£14.21 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.03EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0396Debt Equity Ratio0.0448
Asset Equity Ratio1.5308Cash Equity Ratio0.2731
Quick Ratio1.4662Current Ratio2.21
Price To Book Value0.6551ROCE0

Abingdon Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Abingdon Health PLC Company Financials

Tangible Assets£9.04 m£3.01 m£552,308.00
Intangible Assets£1.23 m£780,000.00£4.52 m
Total Fixed Assets£10.27 m£3.79 m£5.09 m
Stocks£7.89 m£779,000.00£406,414.00
Debtors£9.58 m£1.68 m£759,936.00
Cash & Equivalents£4.98 m£4.39 m£866,152.00
Other Assets000
Total Assets£33.23 m£10.97 m£7.33 m
Creditors within 1 year£10.76 m£6.99 m£844,535.00
Creditors after 1 year£1.14 m£1.23 m£396,981.00
Other Liabilities000
Total Liabilities£11.90 m£8.22 m£1.24 m
Net assets£21.33 m£2.75 m£6.09 m
Called up share capital£24,000.00£15,000.00£15,323.00
Share Premium£24.18 m£13.20 m£13.20 m
Profit / Loss-£6.95 m-£3.38 m-£1.41 m
Other Equity£21.33 m£2.75 m£6.09 m
Preference & Minorities000
Total Capital Employed£21.33 m£2.75 m£6.09 m
Debt Ratio£0.05£0.31£0.06
Assets / Equity1.53081.53081.5308
Cash / Equity0.27310.27310.2731
Cash Flow202120202019
Cash from operating activities-£12.88 m£2.10 m-£908,254.00
Cashflow before financing£7.86 m£5.46 m£468,484.00
Increase in Cash£589,000.00£3.52 m£389,243.00
Turnover£11.62 m£5.24 m£2.28 m
Cost of sales£7.47 m£1.15 m£705,383.00
Gross Profit£4.14 m£4.09 m£1.57 m
Operating Profit-£6.72 m-£3.31 m-£1.40 m
Pre-Tax profit-£6.95 m-£3.38 m-£1.41 m

Abingdon Health PLC Company Background

ActivitiesAbingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also producestests covering areas such as self-test HIV, equine infection, human fertility, blood cancer, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from products sales. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.
Latest Interim Date29 Mar 2022
Latest Fiscal Year End Date18 Nov 2021

Abingdon Health PLC Directors

2021-12-21Dr. Christopher William HandNon-Executive Director,Chairman
2021-12-21Mr. Chris Henry Francis YatesExecutive Director,Chief Executive Officer
2021-11-29Ms. Melanie RossExecutive Director,Chief Financial Officer
2021-11-29Mr. Scott Andrew PageCompany Secretary

Abingdon Health PLC Contact Details

Company NameAbingdon Health PLC
AddressYork Biotech Campus, Sand Hutton, York, YO41 1LZ
Telephone+44 1904406082

Abingdon Health PLC Advisors